Covid 19 News & Insights
Rely on Infectious Disease Advisor
for the latest Covid-19 news, updates and clinical insights to better understand Covid-19’s impact on patient health.
Nirmatrelvir-Ritonavir Effective Against Omicron BA.4, BA.5
Real-world evidence from the Omicron period of the COVID-19 pandemic shows the benefit of nirmatrelvir-ritonavir for vaccinated outpatients and those younger than 65 years of age with non-severe COVID-19 at high risk of hospitalization or death, according to study findings published in The Lancet Infectious Diseases. Investigators sought to examine the real-world effect of nirmatrelvir-ritonavir…
Antibody Response Prolonged With COVID-19 Vaccine-Associated Symptoms
HealthDay News — Messenger RNA severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination leads to transient antibody response, with more sustained response for mRNA-1273 than BNT162b2, for those experiencing vaccine-associated symptoms, and for those with prior SARS-CoV-2 infection, according to a study published online Feb. 4 in Vaccines. Kevin D. Dieckhaus, M.D., from UConn Health in…
COVID-19-Related Financial Disruptions Linked to Child Mental Health
HealthDay News — COVID-19-policy-related financial disruptions were associated with child mental health outcomes, while school disruptions were not, according to a study published online March 13 in JAMA Network Open. Yunyu Xiao, Ph.D., from Weill Cornell Medicine in New York City, and colleagues conducted a cohort study based on the Adolescent Brain Cognitive Development Study COVID-19…
Factors Associated With Worse COVID-19 Outcomes Among Patients With PsA, axSpA
Severe COVID-19 outcomes in patients with psoriasis (PsO), psoriatic arthritis (PsA), and axial spondyloarthritis (axSpA) were found to be associated with older age, male sex, greater comorbidity burden, higher disease activity, and glucocorticoid use, according to the results of an international study published in Annals of the Rheumatic Diseases. Researchers collected information regarding patient demographics,…
Lung Transplant Safe, Effective for COVID-19-Related End-Stage Lung Disease
Patients who underwent lung transplantation for COVID-19-associated end-stage lung disease had a similar 1-year overall survival compared with others undergoing lung transplantation, according to a study in Clinical Infectious Diseases. Researchers sought to determine the characteristics of US patients receiving lung transplantation for COVID-19-related end-stage lung disease, assess long- and short-term outcomes, and compare these…
How COVID-19 Pandemic Affected ADHD Treatment
This is the 5th installment of our 6-part series on mental health issues exacerbated by the COVID-19 pandemic. In this installment, we will discuss identifying and treating ADHD disorders in children and adults in primary care. A 35-year-old woman presents for a 3-month follow-up visit with her primary care provider. The patient was diagnosed with…
Age, Cancer Type Affect COVID-19 Vaccine Uptake in Patients With Cancer
HealthDay News — For patients with cancer, age, cancer type, and comorbidity are associated with differential COVID-19 vaccine uptake rates, according to a study published online March 15 in Cancer. Dax Kurbegov, M.D., from the Sarah Cannon Research Institute in Nashville, Tennessee, and colleagues examined the time to vaccine uptake from Jan. 1, 2021, and factors…
COVID-19-Related Stress During Pregnancy Tied to Poor Postpartum Outcomes
HealthDay News — Antenatal COVID-19-related stress is significantly associated with poor postpartum maternal mental health outcomes, according to a study published online March 14 in JAMA Network Open. Susanne Schweizer, Ph.D., from University of Cambridge in the United Kingdom, and colleagues examined the association of antenatal COVID-19-related stress with postpartum maternal mental health and infant outcomes…
A Comparison of Therapeutic vs Prophylactic Anticoagulation in COVID-19
Therapeutic anticoagulation therapy, compared with prophylactic anticoagulation therapy, significantly increases risk for major bleeding in patients hospitalized with COVID-19, but is more effective in prevention of thromboembolic events. These findings were published in The Clinical Respiratory Journal. Investigators sought to compare efficacy and safety outcomes of therapeutic and prophylactic doses of anticoagulation therapy among patients…
Persistent Bradycardia May Occur After Remdesivir Infusion in Patients With COVID-19
Results of a study published in JAMA Network Open indicate a relationship between bradycardia and remdesivir infusion in the setting of COVID-19 infection. The FACT Pharmacovigilance Project is an ongoing surveillance program designed to evaluate adverse outcomes from nonvaccine-related treatments for COVID-19 infection, with data source from 15 medical centers in the United States. For…
